intelligence360
  • SUBSCRIBE
  • About us
  • Video News Daily
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

Arizona Femtech Startup Prickly Pear Health Secures Institutional Pre-Seed Funding, Surpasses Initial Goal of $250K

Arizona Femtech Startup Prickly Pear Health Secures Institutional Pre-Seed Funding, Surpasses Initial Goal of $250K

February 28, 2025 Craig Etkin

AI-powered digital health platform addresses cognitive wellness during the menopausal transition, backed by Bayless Ventures and AZ Venture Capital Inc.

PHOENIX, Feb. 20, 2025 /PRNewswire/ — Prickly Pear Health, a digital health company focused on brain health during the menopausal transition, announced today that it has secured institutional pre-seed funding led by Bayless Ventures and AZ Venture Capital Inc. The company has surpassed its initial funding target of $250,000, with strong potential to double this figure by Q1 2025.

“Securing institutional backing this early in our journey validates both our mission and market opportunity,” said Imen Maaroufi Clark, Founder and CEO of Prickly Pear Health. “This investment accelerates our ability to address the critical gaps in menopausal health support, particularly around cognitive and neurological wellness.”

The funding round attracted notable investors and advisors, including AZ-VC (Arizona’s largest venture capital fund), Dr. Alyx Porter Umphrey, Neurooncologist at Mayo Clinic; Dr. Heidi Jannenga, Co-founder of WebPT; and Ginny Wright, CEO of Audemars Piguet, Americas. This early institutional support positions Prickly Pear Health as Arizona’s leading femtech startup.

“Prickly Pear Health represents exactly what we look for in early-stage investments,” said James Goulka, CEO and President of AZ Venture Capital Inc. “The combination of a compelling founder story, clear market need, and innovative technology solution presents an exceptional opportunity to transform women’s health.”

Clark’s journey to founding Prickly Pear Health began in North Africa, where she witnessed her mother’s struggles with surgical menopause following an emergency postpartum hysterectomy. This personal experience, combined with her background in technology, drove her to develop solutions for the often-overlooked cognitive and neurological aspects of menopausal transition.

“Issues like brain fog and memory deficits due to hormonal fluctuations are affecting the 28 million women currently in menopausal transition and will continue to grow by 2 million per year,” said Dr. Heidi Jannenga. “With their innovative technological platform, Prickly Pear is poised to help women not just tolerate, but thrive during and beyond their reproductive years with their evidence-based approach to navigating these transition periods. I proudly support Imen as a female founder transforming the brain health approach.”

The platform is leveraging the latest advancements in AI to address hormonal fluctuations’ impact on brain health, particularly during the menopausal transition, and provide personalized insights and recommendations. Prickly Pear Health is redefining how women navigate this inevitable life transition. Currently in closed beta, Prickly Pear is actively developing partnerships with healthcare providers and research institutions to expand its impact.

About Prickly Pear Health

Prickly Pear is a NextGen digital health solution designed to champion brain health during and beyond reproductive years. By integrating conversational AI, behavioral analytics, and wearable technology, the platform delivers personalized insights to support emotional well-being, mental clarity, and cognitive resilience, particularly for women in the menopausal transition. By fostering sustainable lifestyle modifications, the platform empowers them to fuel cognitive performance and optimize overall well-being. To learn more, visit https://pricklypear.io/.

About Bayless Ventures

Bayless Ventures is an early-stage venture capital firm focused on disruptive healthcare technology and technology-enabled services. The firm invests and advises companies from incorporation through Series A funding round. Bayless Ventures is dedicated to supporting the next generation of healthcare leaders that will create a positive shift in the healthcare industry. To learn more about Bayless Ventures, please visit https://baylesshealthventures.com/.

About AZ Venture Capital Inc.

AZ Venture Capital Inc. is an Arizona venture capital fund that invests in pre-seed through Series B rounds of funding of early-stage Arizona startups and early growth companies that solve important customer problems. They invest in software; IT hardware; health tech, including medical devices, diagnostics, and therapeutics; and green tech. AVC has a particular focus on bringing its own and other equity capital sources to founders from traditionally underserved communities. For more information, visit: https://azventurecap.com/.

SOURCE Prickly Pear Health

Copyright © 2025 Cision US Inc.


Venture Capital
Cision, Phoenix, Prickly Pear Health, PRNewswire, Venture Capital

Post navigation

NEXT
Trinity Capital Inc. Provides $15 Million in Growth Capital to Cagent Vascular Inc.
PREVIOUS
Henry AI Raises $4 Million in Seed Funding to Automate Commercial Real Estate Transactions
Comments are closed.
Subscribe for FREE!

intelligence360

intelligence360
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Kimberly-Clark Corporation, one of the world's leading manufacturers of personal care and hygiene products, will establish an $800 million advanced manufacturing facility in Trumbull County, bringing an anticipated 491 new high-quality jobs. For Kimberly-Clark, this new facility would be its first in Ohio and represents not just a strategic expansion, but a decisive step in doubling down on growth in the American market. Spread across more than one million square feet, the Warren facility will provide the manufacturing capacity needed to unleash future growth for Kimberly-Clark’s fastest-growing personal care categories that include Baby & Child Care and Adult & Feminine Care. Warren is in geographic proximity to roughly 117 million consumers and will serve as a strategic hub for the Northeast and Midwest regions. Construction is expected to begin this month and will take up to two years.

In a statement Tamera Fenske, chief supply chain officer at Kimberly-Clark said, “Our investment in Warren is a pivotal step forward in our North America business and strategy.” “By establishing a new, state-of-the-art manufacturing facility in Ohio, we’re enhancing our ability to serve millions of consumers across the Midwest and Northeast with greater speed, agility, and resilience. It’s a once-in-a-career opportunity to build a facility from the ground up that reflects the future of manufacturing, and with the support of local partners like JobsOhio, the Department of Development, Lake to River, Western Reserve Port Authority, and local governments, we have the unique opportunity to create high-quality jobs and long-term economic impact in the region.”

Based in Dallas and employing 46,000 people in 34 countries, the company’s portfolio of brands also includes Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll. Its products are sold in more than 175 countries and territories.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Snorkel AI announced general availability of two new product offerings on the Snorkel AI Data Development Platform: Snorkel Evaluate and Snorkel Expert Data-as-a-Service. These launches advance its mission to turn knowledge into specialized AI—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. In addition, Snorkel AI announced it has raised $100 million in Series D funding at a $1.3 billion valuation, led by Addition. This new funding will fuel continued research and innovation in evaluating and tuning specialized AI systems with expert data.


In a statement Alex Ratner, Co-founder and CEO of Snorkel AI said, “We are seeing a surge of momentum around agentic AI, but specialized enterprise agents aren’t ready for production in most settings.” “Enterprises need domain-specific data and expertise to make this a reality. We’re excited to deliver on this need and help AI innovators develop expert data to bring their LLM and agentic systems into production with our new offerings, which round out Snorkel’s unified AI data development stack.”

Snorkel AI is building the Snorkel AI Data Development Platform for evaluating and tuning specialized AI at scale. Snorkel AI’s offerings, including Snorkel Evaluate and Snorkel Expert Data-as-a-Service, accelerate evaluation and tuning of specialized AI systems with expert data—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. Launched out of the Stanford AI Lab, Snorkel AI’s platform is used in production by Fortune 500 companies, including BNY, Wayfair, and Chubb, as well as across the U.S. federal government, including the U.S. Air Force.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

TicketManager, a global leader in event ticket and guest management solutions for the corporate enterprise, today announced Valeas Capital Partners, a growth-oriented private-equity firm, has acquired a majority stake in the company. Under the terms of the agreement, Valeas is committing $110 million to support TicketManager’s strategic growth plans. TicketManager Co-Founder and CEO Tony Knopp and COO Ken Hanscom will retain a minority interest in the Company. Founded in 2007, TicketManager is the category leader in providing software and services to manage end-to-end event ticket workflow and guest experiences. Serving as the central hub and system of record for data-driven organizations, the platform streamlines every step of the ticket management process. Every year, companies spend more than $600 billion on customer entertainment, yet 43% of corporate tickets are never used and fewer than 20% of organizations leverage modern software to optimize those investments and mitigate compliance risk.

In a statement Tony Knopp, CEO and Co-Founder of TicketManager said, “Live events are an important investment for businesses of all sizes. Whether major global sponsorships, naming rights for stadiums, luxury suites or even a few season tickets for the local team, companies use them to attract and keep customers while building their brands. But in today’s market, many companies struggle with growing pressure to show the value of their ticket spending.” “We knew there was a better way, and that’s why we created TicketManager – to make company tickets easy and prove the return on investment with cutting edge technology and services.”

TicketManager is a leading event- and guest-management platform that empowers companies to make client entertainment easy and drive greater return on investment. It offers convenient and simple technology to manage corporate sports and entertainment tickets, create exceptional guest life-cycle experiences, and measure effectiveness. TicketManager is trusted by more than 500 global brands including Verizon, FedEx, Adidas, Anheuser-Busch, and Mastercard.
Load More... Subscribe

Categories

Recent Posts

  • Bespoken Spirits Announces Successful Close of Series-C Funding Round June 9, 2025
  • Bito Raises $5.7M Seed Extension to Expand AI Code Review Platform with Codebase Awareness June 9, 2025
  • Pillar Biosciences Raises $34.5M in Funding June 9, 2025
  • CloudZero Raises $56M Series C To Redefine Cloud Cost Optimization In The AI Era June 9, 2025

Archives

© 2025   Copyright SI360 Inc. All Rights Reserved.